Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
2
40%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(1)
Terminated(1)

Detailed Status

Active, not recruiting2
Completed1
Enrolling by invitation1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed120%
active_not_recruiting240%
enrolling_by_invitation120%
terminated120%

Recent Activity

2 active trials
Showing 5 of 5
active_not_recruitingnot_applicable

Head to Head Pilot Trial of Mailed Cologuard to Mailed FIT

NCT06173375
active_not_recruiting

Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality

NCT04124406
enrolling_by_invitationnot_applicable

Head to Head Trial of Mailed Cologuard to Mailed FIT

NCT06931860
terminated

Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)

NCT03705013
completed

A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval

NCT02419716

Clinical Trials (5)

Showing 5 of 5 trials
NCT06173375Not Applicable

Head to Head Pilot Trial of Mailed Cologuard to Mailed FIT

Active Not Recruiting
NCT04124406

Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality

Active Not Recruiting
NCT06931860Not Applicable

Head to Head Trial of Mailed Cologuard to Mailed FIT

Enrolling By Invitation
NCT03705013

Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)

Terminated
NCT02419716

A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval

Completed

All 5 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
5